Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-004872
Filing Date
2025-02-04
Accepted
2025-02-04 16:45:43
Documents
64
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1578529
2 ex31-1.htm EX-31.1 13895
3 ex31-2.htm EX-31.2 14316
4 ex32-1.htm EX-32.1 6739
5 ex32-2.htm EX-32.2 7361
6 form10-k_001.jpg GRAPHIC 109275
7 form10-k_002.jpg GRAPHIC 31588
8 form10-k_03.jpg GRAPHIC 19988
9 form10-k_004.jpg GRAPHIC 78743
10 form10-k_005.jpg GRAPHIC 124168
11 form10-k_007.jpg GRAPHIC 13239
12 form10-k_008.jpg GRAPHIC 10432
13 aud_001.jpg GRAPHIC 58121
  Complete submission text file 0001493152-25-004872.txt   6546946

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE telo-20241231.xsd EX-101.SCH 27900
15 XBRL CALCULATION FILE telo-20241231_cal.xml EX-101.CAL 44235
16 XBRL DEFINITION FILE telo-20241231_def.xml EX-101.DEF 137094
17 XBRL LABEL FILE telo-20241231_lab.xml EX-101.LAB 331860
18 XBRL PRESENTATION FILE telo-20241231_pre.xml EX-101.PRE 273594
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 556341
Mailing Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131
Business Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131 786-396-6723
Telomir Pharmaceuticals, Inc. (Filer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41952 | Film No.: 25589075
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)